235 related articles for article (PubMed ID: 34937564)
1. Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma.
Cai X; Zhou J; Deng J; Chen Z
Cancer Cell Int; 2021 Dec; 21(1):701. PubMed ID: 34937564
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinase 19 upregulation correlates with an unfavorable prognosis in hepatocellular carcinoma.
Cai X; Deng J; Zhou J; Cai H; Chen Z
BMC Gastroenterol; 2021 Oct; 21(1):377. PubMed ID: 34649520
[TBL] [Abstract][Full Text] [Related]
3. UHRF1 Could Be a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma.
Li D; Chen B; Zeng Y; Wang H
Int J Gen Med; 2021; 14():6769-6776. PubMed ID: 34675635
[TBL] [Abstract][Full Text] [Related]
4. CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T
Front Oncol; 2021; 11():721644. PubMed ID: 34631549
[TBL] [Abstract][Full Text] [Related]
5. EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma.
Shu Y; He L; Gao M; Xiao F; Yang J; Wang S; Wei H; Zhang F; Wei H
Front Immunol; 2021; 12():780509. PubMed ID: 35069551
[TBL] [Abstract][Full Text] [Related]
6.
Liu S; Zhao W; Li X; Zhang L; Gao Y; Peng Q; Du C; Jiang N
Front Oncol; 2021; 11():713017. PubMed ID: 34595113
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
8. ASRGL1 Correlates With Immune Cell Infiltration in Hepatocellular Carcinoma and Can Serve as a Prognostic Biomarker.
Xue C; Gao P; Cui X; Zhang X; Lei J; Li R; Zhu C; Qin X
Front Oncol; 2021; 11():680070. PubMed ID: 34249720
[TBL] [Abstract][Full Text] [Related]
9. RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma.
Peng H; Zhu E; Wang J; Du X; Wang C; Yang M; Zhang Y
Front Pharmacol; 2022; 13():989655. PubMed ID: 36120364
[No Abstract] [Full Text] [Related]
10. Exploring the Prognostic Value, Immune Implication and Biological Function of
Huang Y; Huang S; Ma L; Wang Y; Wang X; Xiao L; Qin W; Li L; Yuan X
Front Immunol; 2021; 12():723293. PubMed ID: 34899687
[TBL] [Abstract][Full Text] [Related]
11. High expression of SMARCC1 predicts poor prognosis in gastric cancer patients.
Liu S; Cao X; Wu S
Am J Cancer Res; 2022; 12(9):4428-4438. PubMed ID: 36225646
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma.
Jiayu F; Jiang Y; Zhou X; Zhou M; Pan J; Ke Y; Zhen J; Huang D; Jiang W
Aging (Albany NY); 2022 Dec; 14(23):9550-9578. PubMed ID: 36462500
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed SNRPB/D1/D3/E/F/G correlate with poor survival and immune infiltration in hepatocellular carcinoma.
Li FP; Liu GH; Zhang XQ; Kong WJ; Mei J; Wang M; Dai YH
Am J Transl Res; 2022; 14(6):4207-4228. PubMed ID: 35836882
[TBL] [Abstract][Full Text] [Related]
14. Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma.
Kong F; Wang K; Wang L
Discov Oncol; 2022 Nov; 13(1):131. PubMed ID: 36434140
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma.
Jiang J; Liu B; Liu R; Yang W
Cancer Manag Res; 2021; 13():2517-2537. PubMed ID: 33758547
[TBL] [Abstract][Full Text] [Related]
16. ALDH2 is a prognostic biomarker and related with immune infiltrates in HCC.
Yao S; Yin X; Chen T; Chen W; Zuo H; Bi Z; Zhang X; Jing Y; Pang L; Cheng H
Am J Cancer Res; 2021; 11(11):5319-5337. PubMed ID: 34873463
[TBL] [Abstract][Full Text] [Related]
17. The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma.
Guan R; Hong W; Huang J; Peng T; Zhao Z; Lin Y; Yu M; Jian Z
J Gastrointest Oncol; 2020 Dec; 11(6):1305-1321. PubMed ID: 33457003
[TBL] [Abstract][Full Text] [Related]
18. Study on the expression of TOP2A in hepatocellular carcinoma and its relationship with patient prognosis.
Meng J; Wei Y; Deng Q; Li L; Li X
Cancer Cell Int; 2022 Jan; 22(1):29. PubMed ID: 35033076
[TBL] [Abstract][Full Text] [Related]
19. Human Hepatic Cancer Stem Cells (HCSCs) Markers Correlated With Immune Infiltrates Reveal Prognostic Significance of Hepatocellular Carcinoma.
Sang X; Wu F; Wu D; Lin S; Li J; Zhao N; Chen X; Xu A
Front Genet; 2020; 11():112. PubMed ID: 32184801
[TBL] [Abstract][Full Text] [Related]
20.
Xie X; Jiang S; Li X
Front Oncol; 2021; 11():621373. PubMed ID: 33767990
[No Abstract] [Full Text] [Related]
[Next] [New Search]